A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus

Journal of Virological Methods

Volumn 173, Issue 1, 2011, Pages 127-136

  Rosseels, Valérie ^a   Nazé, Florence ^a   De Craeye, Stéphane ^a   Francart, Aurélie ^a   Kalai, Michael ^a   Van Gucht, Steven ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Anesthesia; Brain; Intranasal; Isoflurane; Rabies virus; Volume

Indexed keywords

ISOFLURANE; KETAMINE; XYLAZINE;

ANESTHESIA LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; INOCULATION; INTRANASAL INOCULATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS; VIRUS INFECTIVITY; VIRUS LOAD;

ANESTHETICS, INHALATION; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ISOFLURANE; MICE; RABIES; SURVIVAL ANALYSIS;

ANIMALIA; MUS; RABIES VIRUS;

EID: 79952193561     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.01.019     Document Type: Article

References (24)

1. Astic L., Saucier D., Coulon P., Lafay F., Flamand A. The CVS strain of rabies virus as transneuronal tracer in the olfactory system of mice. Brain Res. 1993, 619:146-156.
2. Bourhy H., Kissi B., Lafon M., Sacramento D., Tordo N. Antigenic and molecular characterization of bat rabies virus in Europe. J. Clin. Microbiol. 1992, 30:2419-2426.
3. Charlton K.M., Casey G.A. Experimental rabies in skunks: oral, nasal, tracheal and intestinal exposure. Can. J. Comp. Med. 1979, 43:168-172.
4. Denis O., van den Brûle S., Heymans J., Havaux X., Rochard C., Huaux F., Huygen K. Chronic intranasal administration of mould spores or extracts to unsensitized mice leads to lung allergic inflammation, hyper-reactivity and remodelling. Immunology 2007, 122:268-278.
5. Dutta M.K., Saha V., Sarkar P. Detection of rabies virus in different tissues of experimentally infected mice at preclinical and postclinical stages of the disease. Indian J. Exp. Biol. 1992, 30:877-880.
6. Gizurarson S. Animal models for intranasal drug delivery studies: a review article. Acta Pharm. Nord. 1990, 2:105-122.
7. Jogani V.V., Shah P.J., Mishra P., Mishra A.K., Misra A.R. Nose-to-brain delivery of tacrine. J. Pharm. Pharmacol. 2007, 59:1199-1205.
8. Johnson N., Phillpotts R., Fooks A.R. Airborne transmission of lyssaviruses. J. Med. Microbiol. 2006, 55:785-790.
9. Klopfleisch R., Teifke J.P., Fuchs W., Kopp M., Klupp B.G., Mettenleiter T.C. Influence of tegument proteins of pseudorabies virus on neuroinvasion and transneuronal spread in the nervous system of adult mice after intranasal inoculation. J. Virol. 2004, 78:2956-2966.
10. Lafay F., Coulon P., Astic L., Saucier D., Riche D., Holley A., Flamand A. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 1991, 183:320-330.
11. Lockhart B.P., Tordo N., Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob. Agents Chemother. 1992, 36:1750-1755.
12. Lodmell D.L., Ewalt L.C. Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice. J. Virol. 1985, 55:788-795.
13. Madhusudana S.N., Tripathi K.K. Oral infectivity of street and fixed rabies virus strains in laboratory animals. Indian J. Exp. Biol. 1990, 28:497-499.
14. Mu J., Jeyanathan M., Small C.L., Zhang X., Roediger E., Feng X., Chong D., Gauldie J., Xing Z. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis. Mol. Ther. 2009, 17:1093-1100.
15. Murphy F.A. Rabies pathogenesis. Arch. Virol. 1977, 54:279-297.
16. Okamoto S., Matsuura M., Akagi T., Akashi M., Tanimoto T., Ishikawa T., Takahashi M., Yamanishi K., Mori Y. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 2009, 27:5896-5905.
17. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
18. Rojo A.I., Montero C., Salazar M., Close R.M., Fernandez-Ruiz J., Sanchez-Gonzalez M.A., de Sagarra M.R., Jackson-Lewis V., Cavada C., Cuadrado A. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur. J. Neurosci. 2006, 24:1874-1884.
19. Servat A., Lutsch C., Delore V., Lang J., Veitch K., Cliquet F. Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model. Vaccine 2003, 22:244-249.
20. Sinchaisri T.A., Nagata T., Yoshikawa Y., Kai C., Yamanouchi K. Immunohistochemical and histopathological study of experimental rabies infection in mice. J. Vet. Med. Sci. 1992, 54:409-416.
21. Smee D.F., Gowen B.B., Wandersee M.K., Wong M.H., Skirpstunas R.T., Baldwin T.J., Hoopes J.D., Sidwell R.W. Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. Int. J. Antimicrob. Agents 2008, 31:352-359.
22. Visweswaraiah A., Novotny L.A., Hjemdahl-Monsen E.J., Bakaletz L.O., Thanavala Y. Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention. Vaccine 2002, 20:3209-3220.
23. Yoneda A., Tuchiya K., Takashima Y., Arakawa T., Tsuji N., Hayashi Y., Matsumoto Y. Protection of mice from rabies by intranasal immunization with inactivated rabies virus. Exp. Anim. 2008, 57:1-9.
24. Zhou S., Kawakami S., Yamashita F., Hashida M. Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice. Cancer Lett. 2009, 287:75-81.